These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 30903212

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.
    Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, Zhou Y, Campolongo P, Cuomo V, Di Marzo V, Vanderschuren LJ.
    J Neurosci; 2012 Oct 24; 32(43):14899-908. PubMed ID: 23100412
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat.
    Parker KE, McCall JG, McGuirk SR, Trivedi S, Miller DK, Will MJ.
    Brain Res; 2015 Aug 27; 1618():309-15. PubMed ID: 26100333
    [Abstract] [Full Text] [Related]

  • 8. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M, Goldberg SR.
    Neuropsychopharmacology; 2005 Nov 27; 30(11):2035-45. PubMed ID: 15812567
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
    Trang T, Sutak M, Jhamandas K.
    Neuroscience; 2007 May 25; 146(3):1275-88. PubMed ID: 17395382
    [Abstract] [Full Text] [Related]

  • 11. Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine.
    Viganò D, Valenti M, Cascio MG, Di Marzo V, Parolaro D, Rubino T.
    Eur J Neurosci; 2004 Oct 25; 20(7):1849-57. PubMed ID: 15380006
    [Abstract] [Full Text] [Related]

  • 12. The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats.
    Altun A, Ozdemir E, Yildirim K, Gursoy S, Durmus N, Bagcivan I.
    Gen Physiol Biophys; 2015 Oct 25; 34(4):433-40. PubMed ID: 26374993
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Deficient social and play behavior in juvenile and adult rats after neonatal cortical lesion: effects of chronic pubertal cannabinoid treatment.
    Schneider M, Koch M.
    Neuropsychopharmacology; 2005 May 25; 30(5):944-57. PubMed ID: 15592349
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intra-accumbal Cannabinoid Agonist Attenuated Reinstatement but not Extinction Period of Morphine-Induced Conditioned Place Preference; Evidence for Different Characteristics of Extinction Period and Reinstatement.
    Khaleghzadeh-Ahangar H, Haghparast A.
    Neurochem Res; 2017 Nov 25; 42(11):3321-3330. PubMed ID: 28780734
    [Abstract] [Full Text] [Related]

  • 18. Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway.
    Caillé S, Parsons LH.
    Neuropsychopharmacology; 2006 Apr 25; 31(4):804-13. PubMed ID: 16123766
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.